arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

BIOFORCE NANOSCIENCES HOLDINGS, INC.

BFNH

— Price unavailable

37 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

BIOFORCE NANOSCIENCES HOLDINGS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC None

FCF / Share $0.00

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

37-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-102.41K

↑ +89.0% —

Operating Margin Operating profit as % of sales

-106.2%

↑ +11.8% —

FCF / Share Free cash flow per share

$0.00

↑ +163.7% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns ↑

100

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	N/M	8.2% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+63%)	17.8% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+256%)	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	100.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	100.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	66.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	89.0% Excellent ↑ Excellent Improving Year-over-year change in net income	3.7% Caution ↑ Caution Improving Year-over-year change in net income	5.0% Fair ↑ Fair Improving Year-over-year change in net income	-7.3% Weak ↑ Weak Improving Year-over-year change in net income	-614.5% Weak ↓ Weak Declining Year-over-year change in net income	-7.6% Weak ↓ Weak Declining Year-over-year change in net income	-7.4% Weak ↓ Weak Declining Year-over-year change in net income	-0.4% Weak ↓ Weak Declining Year-over-year change in net income	-0.6% Weak ↓ Weak Declining Year-over-year change in net income	0.3% Caution ↓ Caution Declining Year-over-year change in net income	7.3% Fair ↑ Fair Improving Year-over-year change in net income	1.6% Caution ↑ Caution Improving Year-over-year change in net income	1.8% Caution ↑ Caution Improving Year-over-year change in net income	4.9% Caution ↑ Caution Improving Year-over-year change in net income	-7.7% Weak ↓ Weak Declining Year-over-year change in net income	5.3% Fair ↑ Fair Improving Year-over-year change in net income	8.7% Fair ↑ Fair Improving Year-over-year change in net income	1.5% Caution ↓ Caution Declining Year-over-year change in net income	3.4% Caution ↑ Caution Improving Year-over-year change in net income	3.5% Caution ↑ Caution Improving Year-over-year change in net income	99.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-507.7% Weak ↑ Weak Improving Year-over-year change in net income	-1761.7% Weak ↑ Weak Improving Year-over-year change in net income	-1664.3% Weak ↑ Weak Improving Year-over-year change in net income	-1229602.4% Weak ↓ Weak Declining Year-over-year change in net income	-134.7% Weak ↓ Weak Declining Year-over-year change in net income	4.7% Caution ↓ Caution Declining Year-over-year change in net income	74.8% Excellent ↑ Excellent Improving Year-over-year change in net income	46.4% Excellent ↑ Excellent Improving Year-over-year change in net income	65.2% Excellent Excellent Year-over-year change in net income	-201.8% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	N/M	—	—	—	21.4% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-106.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-985%)	-120.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1104%)	-219.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1931%)	-149.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1349%)	-120.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1104%)	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-106.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1428%)	-120.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1606%)	-219.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2846%)	-149.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1973%)	-120.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1606%)	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-127.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-87.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-424.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	-0.07x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.09x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.02x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.12x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.13x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.06x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.18x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.08x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.25x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.07x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.22x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.09x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.75x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	—	—	18.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	25.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	40.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-10.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-133.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-134.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-237.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	—	—	-14785.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13567.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-967.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-12.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-22.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-118.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	14.2% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-5%)	19.2% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+28%)	23.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+55%)	32.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+113%)	—	5.4% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-64%)	5.6% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-63%)	5.5% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-63%)	6.7% Caution → Caution Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	6.3% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-58%)	6.7% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-56%)	7.2% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-52%)	8.8% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-41%)	8.5% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-43%)	9.9% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-34%)	10.4% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-30%)	13.3% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-11%)	14.0% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-7%)	15.4% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	19.5% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+30%)	28.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+92%)	34.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+127%)	49.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+231%)	106.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+607%)	—	-42.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-384%)	-13.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-17.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-214%)	-37.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-351%)	-28.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-292%)	-27.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-285%)	-174.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1264%)	-170.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1234%)	—	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Net Debt (USD)	$-6.35K	$-786.00	$-784.00	$-905.00	$-13.80K	$-862.00	$-1.64K	$-667.00	$-640.00	$-638.00	$-686.00	$-654.00	$-686.00	$-734.00	$-750.00	$-9.23K	$-11.11K	$-11.11K	$-27.30K	$-27.30K	$-31.84K	$-39.87K	$-39.87K	$-39.87K	$-46.87K	$-52.90K	$-46.93K	$-40.97K	$-35.12K	$-29.39K	$-23.89K	$-23.88K	$-18.82K	$-14.32K	$-14.32K	$-14.32K	$-14.32K

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Basic EPS, GAAP (USD)	$0.00	$0.00	$0.00	$0.00	$-0.03	$-0.01	$0.00	$0.00	$0.00	$-0.01	$0.00	$0.00	—	$-0.03	$0.00	$0.00	$29.27M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$0.00	—	$-0.00	—	$-0.00	—	—	—	$-0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.02	$-0.02	$-0.01	$-0.01	$-0.01	$-0.08	$-0.07	$-0.07	$-0.07	$-0.06	$-0.06	$-0.05	$-0.05	$-0.05	$-0.04	$-0.04	$-0.03	$-0.03	$-0.03	$-0.02	$-0.02	$-0.01	$-0.02	$-0.01	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	$0.00	—	—	—
Tangible Book Value per Share (USD)	$-0.02	$-0.02	$-0.01	$-0.01	$-0.01	$-0.08	$-0.07	$-0.07	$-0.07	$-0.06	$-0.06	$-0.05	$-0.05	$-0.05	$-0.04	$-0.04	$-0.03	$-0.03	$-0.03	$-0.02	$-0.02	$-0.01	$-0.02	$-0.01	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	$0.00	—	—	—
Basic Weighted Avg Shares (shares)	33.52M	—	33.52M	—	32.25M	—	29.27M	29.27M	29.27M	—	29.27M	29.27M	—	—	29.27M	29.27M	0	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$-720.95K	$-618.54K	$-499.94K	$-384.02K	$-261.24K	$-2.30M	$-2.18M	$-2.06M	$-1.95M	$-1.82M	$-1.70M	$-1.59M	$-1.48M	$-1.35M	$-1.23M	$-1.11M	$-994.27K	$-861.86K	$-741.16K	$-627.30K	$-504.99K	$-359.91K	$-237.34K	$-119.42K	$7.29K	$47.31K	$48.35K	$41.92K	$34.20K	$29.80K	$23.93K	—	—	$8.20K	—	—	—
Total Equity (USD)	$-720.95K	$-618.54K	$-499.94K	$-384.02K	$-261.24K	$-2.30M	$-2.18M	$-2.06M	$-1.95M	$-1.82M	$-1.70M	$-1.59M	$-1.48M	$-1.35M	$-1.23M	$-1.11M	$-994.27K	$-861.86K	$-741.16K	$-627.30K	$-504.99K	$-359.91K	$-237.34K	$-119.42K	$7.29K	$47.31K	$48.35K	$41.92K	$34.20K	$29.80K	$23.93K	$16.34K	$14.10K	$8.20K	—	—	$2.29K

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	$5.96K	$5.96K	$5.85K	$5.74K	$5.51K	$5.06K	—	—	—	—	—
Net Income, GAAP (USD)	$-102.41K	$-118.61K	$-115.92K	$-122.78K	$-934.65K	$-123.16K	$-122.02K	$-114.44K	$-130.81K	$-114.41K	$-113.61K	$-113.93K	$-130.00K	$-114.73K	$-122.59K	$-115.78K	$-132.41K	$-120.70K	$-113.86K	$-122.31K	$-145.08K	$-122.56K	$-117.92K	$-126.71K	$-158.04M	$-20.17K	$-6.33K	$-7.18K	$-12.85K	$-8.59K	$-6.64K	$-28.53K	$-23.97K	$-24.66K	$-2.20K	—	—
Operating Cash Flow (USD)	$7.09K	$-10.92K	$-11.12K	$-27.89K	$-15.21K	$-14.84K	—	—	$-17.58K	$-7.09K	—	—	$-23.05K	$-9.43K	—	—	$-32.94K	$-9.04K	—	—	$-32.35K	$-11.15K	—	—	$-39.63K	$-10.26K	—	—	$-7.43K	$-5.04K	—	$-21.48K	$-25.37K	$-11.71K	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 37 quarters

BIOFORCE NANOSCIENCES HOLDINGS, INC.

Analytical Summary

37-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BFNH with peers